Cymbalta (duloxetine) typically needs four to six weeks at an adequate dose before you can fairly judge whether it’s working. If you’ve hit that window and your core symptoms haven’t improved, or if symptoms that once improved are creeping back, those are the clearest signals that the medication isn’t doing its job. Knowing what to look for can help you have a more productive conversation with your prescriber about next steps.
The Four-to-Six-Week Rule
Clinicians use a standardized depression questionnaire to measure whether an antidepressant is pulling its weight. After four to six weeks on a therapeutic dose, they look for a drop of at least five points on that scale. A drop of only two to four points is considered “probably inadequate” and usually prompts a dose increase. A drop of one point, no change, or a score that goes up signals that the current approach isn’t working and needs to be reconsidered.
You don’t need to score yourself on a clinical scale to apply this logic. Think about the specific symptoms that led you to start Cymbalta, whether that’s persistent low mood, anxiety that interferes with your day, or chronic pain. After six weeks, ask yourself honestly: are those symptoms meaningfully better, slightly better, or unchanged? “Slightly better” may not be enough.
Signs Your Depression or Anxiety Isn’t Responding
The most telling signs mirror the symptoms you started with. If you’re still experiencing low mood most of the day, changes in sleep or appetite, loss of interest in things you used to enjoy, or withdrawing from people, the medication likely isn’t providing adequate relief. For generalized anxiety, persistent worry, muscle tension, restlessness, and difficulty concentrating that haven’t eased after a full trial are all red flags.
One subtlety worth noting: Cymbalta can improve some symptoms while leaving others untouched. You might sleep better but still feel emotionally flat, or your anxiety might ease while your energy stays in the basement. Partial improvement is still a sign the medication may not be the right fit on its own, though your prescriber might consider adding something rather than switching entirely.
Signs Your Pain Condition Isn’t Responding
Cymbalta is also prescribed for fibromyalgia, diabetic nerve pain, and chronic musculoskeletal pain. For nerve pain, large reviews show that about 50% more people get meaningful pain relief (at least a 50% reduction) with Cymbalta compared to a placebo over 12 weeks. That’s a real effect, but it also means plenty of people don’t respond.
For fibromyalgia specifically, the evidence is more modest. The benefit may come more from improving mood and mental symptoms than from directly reducing physical pain. If your pain levels, fatigue, and tenderness haven’t budged after two to three months at the full dose of 60 mg per day, the medication probably isn’t providing enough benefit for your pain condition.
Early Side Effects vs. True Failure
This distinction trips people up. In the first few weeks, Cymbalta commonly causes nausea (reported by about 18% of users), dry mouth, constipation, and drowsiness. These side effects can make you feel worse before you feel better, and they can mimic some of the very symptoms you’re trying to treat. Drowsiness can look like worsening fatigue. Nausea can kill your appetite. Irritability from adjusting to the drug can feel like your anxiety is getting worse.
The key difference is timing. Side effects tend to be most intense in the first one to two weeks and then gradually fade. If you’re three weeks in and dealing mostly with nausea and fatigue but your mood is starting to lift, that’s a sign the drug is working and your body is still adjusting. If you’re six weeks in and your original symptoms are unchanged on top of new side effects, that’s a clearer picture of failure. In clinical studies, most treatment-related side effects were mild to moderate and decreased or resolved with continued use.
When Cymbalta Stops Working After Initial Success
Some people respond well to Cymbalta for months or even years, then notice their symptoms gradually returning. This is sometimes called antidepressant tachyphylaxis, or informally, the “poop-out effect.” It’s distinct from a new depressive episode because the pattern of symptoms tends to look different from classic depression.
The hallmark signs include apathy or decreased motivation (even without sadness), mental dullness or foggy thinking, fatigue, sleep disturbances, weight gain, and sexual dysfunction. Researchers have identified this specific cluster as characteristic of tachyphylaxis rather than a relapse of the original condition. If your depression originally felt like sadness and hopelessness but now feels more like emotional numbness and low drive, the medication itself may be the issue.
Your Dose May Not Be High Enough
Before concluding that Cymbalta has failed, it’s worth confirming you’ve had a real trial at an adequate dose. For depression, the therapeutic dose is 60 mg per day, though many people start at 30 mg for the first week. For generalized anxiety disorder, the target is also 60 mg daily. For fibromyalgia, the maximum recommended dose is 60 mg per day.
If you’ve been sitting at 30 mg for several weeks, you haven’t yet had a full trial. Some prescribers are cautious about increasing the dose, so it’s worth asking directly whether you’re at the target. For depression and anxiety, some clinicians do push above 60 mg even though studies haven’t consistently shown additional benefit at higher doses. This is a judgment call that depends on your individual response.
Genetics Can Affect How You Process the Drug
Your body breaks down Cymbalta using specific liver enzymes. People carry different genetic variants of these enzymes, and the differences matter. Ultrarapid metabolizers clear the drug too quickly, leaving levels too low to be effective. Poor metabolizers clear it too slowly, leading to higher blood levels and more side effects. Research has found that people who metabolize duloxetine faster tend to get more anxiety relief, while slower metabolizers may experience less benefit for anxiety symptoms, likely because side effects become intolerable before the dose can be optimized.
If you’ve tried multiple antidepressants without success, pharmacogenomic testing (a simple cheek swab) can reveal whether your metabolism is working against you. It won’t tell you exactly which drug will work, but it can explain why certain ones haven’t.
What Happens If You and Your Prescriber Decide to Switch
If Cymbalta isn’t working, the typical next steps are increasing the dose, adding a second medication, or switching to a different antidepressant. Patients who don’t improve after two adequate medication trials within 20 to 30 weeks are generally referred for a more comprehensive psychiatric evaluation to reconsider the diagnosis and treatment plan.
One critical point: do not stop Cymbalta abruptly. Withdrawal symptoms can begin within one to two days and include nausea, headache, dizziness, irritability, insomnia, electric shock sensations in the brain (commonly called “brain zaps”), and excessive sweating. These can last anywhere from a few days to several weeks. Cymbalta is particularly notorious for difficult withdrawal compared to other antidepressants. A gradual taper over days to weeks significantly reduces the severity.
Switching strategies vary. The most cautious approach is to taper off Cymbalta completely, wait a washout period, then start the new medication. A faster approach called cross-tapering involves gradually lowering Cymbalta while slowly introducing the new drug, so there’s overlap. This requires careful clinical judgment because combining certain antidepressants can cause dangerous interactions, including serotonin syndrome. Your prescriber will choose the strategy based on which medication you’re moving to and how urgently you need relief.